Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants
Tokhir Dadaev(Institute of Cancer Research), Lorelei A. Mucci(American Cancer Society), N.G. Burnet(University of Cambridge), Ezequiel Anokian(Institute of Cancer Research), Teuvo L.J. Tammela(Tampere University), Leire Moya(Translational Research Institute), Ian M. Thompson(The University of Texas at San Antonio Health Science Center), Nora Pashayan(MRC Epidemiology Unit), Wayne D. Tilley(The University of Adelaide), Susan M. Gapstur(Centre international de recherche sur le cancer), Henrik Grönberg(Karolinska Institutet), Tobias Nordström(Karolinska Institutet), Catherine M. Tangen(American Urological Association), Demetrius Albanes(National Cancer Institute), Judith A. Clements(Translational Research Institute), Anssi Auvinen(Tampere University of Applied Sciences), Kenneth Muir(Manchester Academic Health Science Centre), Mahbubl Ahmed(Institute of Cancer Research), Alison M. Dunning(University of Cambridge), Stephanie J. Weinstein(National Institutes of Health), Suzanne K. Chambers(University of Southern Queensland), Fredrick R. Schumacher(Harvard University), Csilla Sipeky(University of Turku), Jyotsna Batra(Bond University), Chee Goh(Institute of Cancer Research), Ali Amin Al Olama(Institute of Cancer Research), Xin Sheng(University of Southern California), Mark N. Brook(Institute of Cancer Research), Koveela Govindasami(Institute of Cancer Research), Brian D. Carter(American Cancer Society), Paul J. Newcombe(University of Cambridge), Edward J. Saunders(Institute of Cancer Research), Sarah Wakerell(Institute of Cancer Research), Johanna Schleutker(University of Turku), Martina Mijušković(Institute of Cancer Research), Sara Benlloch(Institute of Cancer Research), Catharine West(University of Manchester), Clara Cieza-Borrella(Institute of Cancer Research), Lisa G. Horvath(The University of Sydney), Victoria L. Stevens(American Cancer Society), Alicja Wolk(Karolinska Institutet), Paul D.P. Pharoah(Cedars-Sinai Medical Center), Gail P. Risbridger(Discovery Institute), Zhuo Zhang(University of Southern California), Niclas Håkansson(Cancer Prevention Institute of California), Sonja I. Berndt(Institute of Cancer Research), Artitaya Lophatananon(University of Warwick), Phyllis J. Goodman(Translational Research Institute), Markus Aly(Karolinska University Hospital), Daniel Leongamornlert(University of Southern California)
Cited by 113
Related Papers
Frailty in Older Adults: Evidence for a Phenotype
|The Journals of Gerontology Series A|2001|24.4k
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
|New England Journal of Medicine|2014|3.5k
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
|New England Journal of Medicine|2003|2.6k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k